methyldopa has been researched along with Drug Withdrawal Symptoms in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (90.32) | 18.7374 |
1990's | 2 (6.45) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (3.23) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bar-Cohen, Y; Rivero, N; Su, JA; Tang, W | 1 |
Hubbell, FA; Weber, MA | 1 |
Kruger, SA; van der Merwe, CJ | 1 |
Houston, MC | 2 |
Cummings, DM; Vlasses, PH | 1 |
Johnson, JM | 1 |
Prichard, BN | 1 |
Conway, EL; Jarrott, B; Lewis, S; Louis, WJ; Summers, R | 1 |
Dackis, CA; Gold, MS; Washton, AM | 1 |
Fersel, J; Melman, A; Weinstein, P | 1 |
Garibova, TL; Voronina, TA | 1 |
Whitsett, TL | 1 |
Harris, DB; Stiff, JL | 1 |
Bune, AJ; Chalmers, JP; Graham, JR; Howe, PR; West, MJ; Wing, LM | 1 |
Sotaniemi, EA; Ylikallio, A | 1 |
Koch, HF; Webster, J | 1 |
Goldberg, AD; Raftery, EB; Wilkinson, P | 1 |
Eger, EI; Smith, M; Smith, RA; Winter, PM | 1 |
Campanini, T; Catalano, A; De Risio, C; Forino, V | 1 |
Frewin, DB; Penhall, RK | 1 |
McDevitt, DG; Scott, JN | 1 |
Dollery, CT | 1 |
Kosman, ME | 1 |
Alexander, CP; Burden, AC | 1 |
Fujita, T; Ono, A | 1 |
Holzgang, AJ; Labbate, LA | 1 |
Deneau, GA; Seevers, MH; Segal, M | 1 |
Bauer, GE; Lewis, RG; Maclachlan, I; Mitchell, AS; Raftos, J; Stokes, GS; Young, AA | 1 |
Gunne, LM | 1 |
7 review(s) available for methyldopa and Drug Withdrawal Symptoms
Article | Year |
---|---|
Abrupt cessation of treatment in hypertension: consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome.
Topics: Acute Disease; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bethanidine; Blood Pressure; Clonidine; Guanabenz; Heart Failure; Humans; Hypertension; Methyldopa; Myocardial Infarction; Pressoreceptors; Prospective Studies; Substance Withdrawal Syndrome; Syndrome; Time Factors | 1981 |
Antihypertensive drug withdrawal syndrome.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Catecholamines; Clonidine; Humans; Methyldopa; Risk; Substance Withdrawal Syndrome | 1982 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Clonidine; Depressive Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Methyldopa; Metoprolol; Migraine Disorders; Propranolol; Reserpine; Schizophrenia; Substance Withdrawal Syndrome | 1984 |
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihypertensive Agents; Asthma; Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Ethanolamines; Female; Heart Failure; Humans; Hydralazine; Hypertension; Hypertension, Renal; Infusions, Parenteral; Kidney Failure, Chronic; Labetalol; Methyldopa; Parasympathetic Nervous System; Pheochromocytoma; Pregnancy; Pregnancy Complications, Cardiovascular; Substance Withdrawal Syndrome; Tetanus | 1984 |
The involvement of central alpha adrenoceptors in the antihypertensive actions of methyldopa and clonidine in the rat.
Topics: Animals; Blood Pressure; Brain; Clonidine; Heart Rate; Humans; Methyldopa; Rats; Receptors, Adrenergic, alpha; Sleep, REM; Substance Withdrawal Syndrome | 1984 |
The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
Topics: Adult; Baclofen; Clonidine; Drug Therapy, Combination; Electric Stimulation Therapy; Endorphins; Ethanol; Female; Humans; Locus Coeruleus; Male; Methyldopa; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1984 |
Aspects of tolerability of centrally acting antihypertensive drugs.
Topics: Antihypertensive Agents; Clonidine; Humans; Imidazoles; Methyldopa; Reserpine; Substance Withdrawal Syndrome | 1996 |
3 trial(s) available for methyldopa and Drug Withdrawal Symptoms
Article | Year |
---|---|
The antihypertensive effect of guanfacine compared with methyldopa.
Topics: Adrenergic alpha-Agonists; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Guanfacine; Guanidines; Humans; Hypertension; Indoles; Isoindoles; Male; Methyldopa; Middle Aged; Phenylacetates; Pulse; Substance Withdrawal Syndrome; Sulfonamides; Time Factors | 1980 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Clonidine; Depressive Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Methyldopa; Metoprolol; Migraine Disorders; Propranolol; Reserpine; Schizophrenia; Substance Withdrawal Syndrome | 1984 |
Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Guanfacine; Guanidines; Humans; Hypertension; Methyldopa; Norepinephrine; Phenylacetates; Substance Withdrawal Syndrome | 1981 |
22 other study(ies) available for methyldopa and Drug Withdrawal Symptoms
Article | Year |
---|---|
Prenatal exposure to methyldopa leading to hypertensive crisis and cardiac failure in a neonate.
Topics: Adrenergic Agonists; Female; Heart Failure; Humans; Hypertension; Hypertension, Pregnancy-Induced; Infant, Newborn; Methyldopa; Pregnancy; Prenatal Exposure Delayed Effects; Substance Withdrawal Syndrome | 2014 |
Adverse effects of sudden withdrawal of antihypertensive medication.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Clonidine; Drug Therapy, Combination; Humans; Methyldopa; Norepinephrine; Substance Withdrawal Syndrome; Sympathetic Nervous System; Syndrome | 1980 |
Abrupt discontinuation of antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bethanidine; Clonidine; Drug Therapy, Combination; Humans; Hypertension; Methyldopa; Prospective Studies; Substance Withdrawal Syndrome | 1981 |
Further studies on the effect of chronic alpha-methyldopa administration upon the central nervous system and sexual function in male rats.
Topics: Animals; Carbidopa; Central Nervous System; Erectile Dysfunction; Humans; Libido; Male; Methyldopa; Norepinephrine; Penis; Rats; Reflex; Sexual Behavior, Animal; Substance Withdrawal Syndrome; Yohimbine | 1984 |
Clonidine and methyldopa--any role for hypertension now?
Topics: Clonidine; Humans; Hypertension; Methyldopa; Substance Withdrawal Syndrome | 1984 |
[Role of GABA-ergic and dopaminergic mechanisms in the withdrawal syndrome after discontinuation of long-term phenazepam administration].
Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Brain; Dihydroxyphenylalanine; Disulfiram; Dopamine; gamma-Aminobutyric Acid; Humans; Male; Methyldopa; Rats; Semicarbazides; Substance Withdrawal Syndrome; Valproic Acid | 1980 |
Abrupt cessation of treatment with centrally acting antihypertensive agents. A review.
Topics: Antihypertensive Agents; Blood Pressure; Clonidine; Humans; Hypertension; Methyldopa; Renin-Angiotensin System; Substance Withdrawal Syndrome; Sympathetic Nervous System; Time Factors | 1983 |
Clonidine withdrawal complicated by amitriptyline therapy.
Topics: Aged; Amitriptyline; Anxiety; Clonidine; Female; Humans; Hypertension; Intraoperative Care; Methyldopa; Nitroprusside; Postoperative Care; Propranolol; Substance Withdrawal Syndrome; Tachycardia | 1983 |
Drug metabolism and liver function after methyldopa withdrawal.
Topics: Age Factors; Aged; Female; Humans; Liver; Liver Function Tests; Methyldopa; Middle Aged; Pharmaceutical Preparations; Substance Withdrawal Syndrome | 1980 |
Blood pressure and heart rate and withdrawal of antihypertensive drugs.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Clonidine; Female; Ganglionic Blockers; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Methyldopa; Middle Aged; Substance Withdrawal Syndrome | 1977 |
Convulsions in mice after anesthesia.
Topics: Anesthetics; Animals; Cyclopropanes; Ether; Ethers; Ethylenes; Humans; Methyldopa; Mice; Mice, Inbred ICR; Nitrous Oxide; Reserpine; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1979 |
[Tardive dyskinesia. Synthetic-critical review and case contribution].
Topics: Adult; Aged; Baclofen; Dyskinesia, Drug-Induced; Female; Humans; Iatrogenic Disease; Male; Mental Disorders; Methyldopa; Middle Aged; Pyridoxine; Substance Withdrawal Syndrome; Tetrabenazine; Tranquilizing Agents; Valproic Acid | 1977 |
Rebound hypertension after sudden discontinuation of methyldopa therapy.
Topics: Humans; Hypertension; Male; Methyldopa; Middle Aged; Substance Withdrawal Syndrome | 1977 |
Letter: Rebound hypertension after acute methyldopa withdrawal.
Topics: Aged; Female; Humans; Hypertension; Methyldopa; Substance Withdrawal Syndrome | 1976 |
Centrally acting alpha-adrenoceptor agonists in hypertension: mechanisms and their role in therapy.
Topics: Animals; Brain; Clonidine; Humans; Hypertension; Male; Methyldopa; Neurons; Substance Withdrawal Syndrome | 1976 |
Evaluation of clonidine hydrochloride (Catapres). A new antihypertensive agent.
Topics: Administration, Oral; Blood Pressure; Cardiac Output; Clonidine; Diuretics; Drug Evaluation; Drug Synergism; Heart Rate; Humans; Hypertension; Injections, Intravenous; Methyldopa; Posture; Substance Withdrawal Syndrome; Vascular Resistance | 1975 |
Rebound hypertension after acute methyldopa withdrawal.
Topics: Aged; Humans; Hypertension; Male; Methyldopa; Substance Withdrawal Syndrome | 1976 |
[Tolerance and withdrawal syndrome].
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Antihypertensive Agents; Clonidine; Cyclic AMP; Drug Tolerance; Endorphins; Humans; Methyldopa; Neurotransmitter Agents; Substance Withdrawal Syndrome | 1992 |
Manic syndrome after discontinuation of methyldopa.
Topics: Bipolar Disorder; Humans; Hypertension; Male; Methyldopa; Middle Aged; Substance Withdrawal Syndrome | 1989 |
Levels and distribution of central nervous system amines in normal and morphine-dependent monkeys.
Topics: Animals; Behavior, Animal; Brain Chemistry; Caudate Nucleus; Cerebellum; Cerebral Cortex; Dopamine; Haplorhini; Humans; Hypothalamus; Iproniazid; Macaca; Medulla Oblongata; Mesencephalon; Methyldopa; Morphine; Norepinephrine; Pons; Reserpine; Serotonin; Spinal Cord; Substance Withdrawal Syndrome; Substance-Related Disorders; Thalamus; Thebaine | 1972 |
Clonidine in the treatment of severe hypertension.
Topics: Adult; Anesthesia, General; Cerebrovascular Disorders; Clonidine; Coronary Disease; Depression; Humans; Hypertension; Hypertension, Malignant; Hypertension, Renal; Kidney; Male; Methyldopa; Middle Aged; Sexual Behavior; Substance Withdrawal Syndrome | 1973 |
Some pharmacological agents modifying the morphine abstinence syndrome in dogs.
Topics: Animals; Dihydroxyphenylalanine; Dogs; Drug Tolerance; Humans; Methyldopa; Methyltyrosines; Morphine; Nalorphine; Nialamide; Reserpine; Substance Withdrawal Syndrome | 1965 |